In this PharmaTalk episode, John Potthoff, Ph.D., explains the benefits of decentralized clinical trials. He recently spoke with CRAACO quarterly news writer, Danny McCarthy, to discuss why he believes that decentralized clinical trials can be more patient-friendly, how it epitomizes clinical research as a care option, and how the model helps to access patients who have no other way of participating in trials.

When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us